Results: Six hyperacute-phase signature genes (Pip5k1c, Nlgn2, Fzd2, Cd86, Agpat1, and Degs2) were identified in the hyperacute phase of AIS. This evidence concerns the gene AGPAT1 and androgen insensitivity syndrome.